Delivery Order SPE2DB24D2105-SPE2DB25FAQHL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $1,716.59. The award, issued on June 9, 2025, with an ultimate completion date of June 10, 2025, represents a non-set-aside competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a firm fixed price of $1,138.42. This non-set-aside contract, with an ultimate completion date of August 1, 2025, represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Viberzi 75 mg tablets (60 count) valued at $2,354.21. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, on July 24, 2025, for the supply of Viberzi 100 mg tablets (60-count). This firm fixed price delivery order, valued at $1,184.87, is classified as a non-set-aside contract and is expected to reach ultimate completion by July 25, 2025, with performance occurring at AmerisourceBergen's Conshohocken...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,960.49 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count) on July 15, 2025, with completion scheduled for July 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $2,136.20 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a firm fixed price of $1,149.76, with an ultimate completion date of June 3, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Viberzi 100 mg tablets (60-count) at a ceiling value of $3,587.92 under a firm fixed price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively determined with no...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-set-aside contract with performance occurring at the company's corporate office in Conshohocken, Pennsylvania. The award represents a competitive delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB25FAQHLDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $1,093.82 and an ultimate completion date of September 29, 2025. This is a non-set-aside competitive award representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order leverages AmerisourceBergen's prime position within DLA's comprehensive pharmaceutical supply vehicle, which enables the company to distribute a broad range of pharmaceutical products, medical supplies, specialty medications, and vaccines to support military healthcare systems globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of federal contract awards with DLA covering diverse therapeutic domains and product categories. The current order for Viberzi, used to treat irritable bowel syndrome, exemplifies the company's role in providing critical pharmaceutical commodities to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/26/25 |